What is the recommended treatment for dysentery?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Dysentery Treatment

For dysentery (bloody diarrhea), azithromycin is the first-line antibiotic of choice, given as either a single 1000 mg dose or 500 mg daily for 3 days in adults, with fluoroquinolones reserved as alternatives only in regions without high rates of fluoroquinolone-resistant Campylobacter. 1

Initial Assessment and Antibiotic Selection

The most recent high-quality guidelines (2017) prioritize azithromycin over other antibiotics for dysentery based on:

  • Superior efficacy against fluoroquinolone-resistant Campylobacter, which now exceeds 90% resistance in Southeast Asia and is increasingly common worldwide 1
  • Effectiveness against all major dysentery pathogens: Shigella, Campylobacter, enteroinvasive E. coli, Salmonella, Aeromonas, and Plesiomonas 1
  • Strong evidence for mortality reduction: Shigella infection carries a 2.8-fold increased mortality risk, making appropriate antibiotic treatment critical 2

Specific Dosing Regimens

Adults:

  • Azithromycin: 1000 mg single dose OR 500 mg daily for 3 days 1
  • Alternative if azithromycin unavailable: Ciprofloxacin 750 mg single dose or 500 mg daily for 3 days (only in areas with known low fluoroquinolone resistance) 1

Children:

  • Azithromycin is preferred for empiric therapy based on local susceptibility patterns 3
  • Third-generation cephalosporin for infants <3 months with neurologic involvement 3
  • Avoid rifaximin - ineffective for invasive pathogens causing dysentery 1

Critical Clinical Pitfalls

Do NOT use loperamide in dysentery. Antimotility agents are contraindicated in bloody diarrhea or febrile diarrhea at any age due to risk of toxic megacolon 4. Loperamide should not be given to children <18 years with acute diarrhea 4.

Reassess at 48 hours. If no clinical improvement after 2 days, switch to an alternative antibiotic recommended for local resistance patterns 5. If still no improvement after another 2 days, refer for stool microscopy to evaluate for amebiasis 5.

When Amebiasis is Suspected

Consider amebic dysentery only if:

  • Microscopy shows Entamoeba histolytica trophozoites (not just white cells), OR
  • Two different antibiotics for shigellosis have failed 5

Metronidazole dosing for amebiasis:

  • Children: 30 mg/kg/day for 5-10 days
  • Adults: 750 mg three times daily for 5-10 days 5

Geographic and Resistance Considerations

The 2017 guidelines supersede older recommendations (1992) that listed ampicillin and TMP-SMX as first-line agents 5. These older regimens are no longer appropriate due to widespread multidrug resistance in Shigella strains globally 5.

Fluoroquinolone resistance has emerged in:

  • Campylobacter (>90% in Thailand, increasing globally) 1
  • Shigella and Salmonella from India and sub-Saharan Africa 1

Supportive Care is Essential

Rehydration takes priority over antibiotics:

  • Reduced osmolarity oral rehydration solution (ORS) for mild-moderate dehydration 4
  • IV lactated Ringer's or normal saline for severe dehydration, shock, or altered mental status 4
  • Continue breastfeeding and resume age-appropriate diet immediately after rehydration 4

Who Should NOT Receive Empiric Antibiotics

  • Asymptomatic contacts of dysentery patients 4, 3
  • Patients with STEC O157 or Shiga toxin 2-producing strains (antibiotics increase HUS risk) 4, 3
  • Most cases of acute watery diarrhea without dysentery 4

Special Populations Requiring Empiric Treatment

Even without confirmed diagnosis, treat empirically if:

  • Infants <3 months with suspected bacterial etiology 3
  • Fever ≥38.5°C with recent international travel 3
  • Immunocompromised patients with severe bloody diarrhea 3
  • Clinical sepsis with suspected enteric fever 3

The evidence strongly supports azithromycin as superior to fluoroquinolones for dysentery in the current era of antimicrobial resistance, with the caveat that local susceptibility patterns should guide final antibiotic selection when available 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.